Atlas Trials

A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck

Clinical trial NCT02054442 · UNKNOWN

Trial details

NCT number
NCT02054442
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Squamous Cell Carcinoma of the Head and Neck
Start date
2016-08-01
Primary completion
2021-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.